Sánchez M - Search Results

1

Autologous bioscaffolds based on different concentrations of platelet rich plasma and synovial fluid as a vehicle for mesenchymal stem cells.

Garate A, Sánchez P, Delgado D, Bilbao AM, Muiños-López E, Granero-Moltó F, Orive G, Prosper F, Pedraz JL, Sánchez M. Garate A, et al. Among authors: sanchez m, sanchez p. J Biomed Mater Res A. 2018 Feb;106(2):377-385. doi: 10.1002/jbm.a.36247. Epub 2017 Oct 17. J Biomed Mater Res A. 2018. PMID: 28960933

2

Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities.

Anitua E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, Azofra J, Andia I. Anitua E, et al. Among authors: sanchez m. J Biomed Mater Res A. 2006 May;77(2):285-93. doi: 10.1002/jbm.a.30585. J Biomed Mater Res A. 2006. PMID: 16400654

3

New insights into and novel applications for platelet-rich fibrin therapies.

Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I. Anitua E, et al. Among authors: sanchez m. Trends Biotechnol. 2006 May;24(5):227-34. doi: 10.1016/j.tibtech.2006.02.010. Epub 2006 Mar 15. Trends Biotechnol. 2006. PMID: 16540193 Review.

4

The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.

Anitua E, Sánchez M, Orive G, Andía I. Anitua E, et al. Among authors: sanchez m. Biomaterials. 2007 Nov;28(31):4551-60. doi: 10.1016/j.biomaterials.2007.06.037. Epub 2007 Jul 30. Biomaterials. 2007. PMID: 17659771 Review.

5

Delivering growth factors for therapeutics.

Anitua E, Sánchez M, Orive G, Andia I. Anitua E, et al. Among authors: sanchez m. Trends Pharmacol Sci. 2008 Jan;29(1):37-41. doi: 10.1016/j.tips.2007.10.010. Epub 2007 Nov 26. Trends Pharmacol Sci. 2008. PMID: 18037168 Review.

6

Shedding light in the controversial terminology for platelet rich products.

Anitua E, Sánchez M, Orive G, Andía I. Anitua E, et al. Among authors: sanchez m. J Biomed Mater Res A. 2009 Sep 15;90(4):1262-3. doi: 10.1002/jbm.a.32143. J Biomed Mater Res A. 2009. PMID: 18646198 No abstract available.

7

Fibroblastic response to treatment with different preparations rich in growth factors.

Anitua E, Sánchez M, Zalduendo MM, de la Fuente M, Prado R, Orive G, Andía I. Anitua E, et al. Among authors: sanchez m. Cell Prolif. 2009 Apr;42(2):162-70. doi: 10.1111/j.1365-2184.2009.00583.x. Epub 2009 Feb 24. Cell Prolif. 2009. PMID: 19250293 Free PMC article.

8

Platelet-rich therapies in the treatment of orthopaedic sport injuries.

Sánchez M, Anitua E, Orive G, Mujika I, Andia I. Sánchez M, et al. Sports Med. 2009;39(5):345-54. doi: 10.2165/00007256-200939050-00002. Sports Med. 2009. PMID: 19402740 Review.

9

Potential of endogenous regenerative technology for in situ regenerative medicine.

Anitua E, Sánchez M, Orive G. Anitua E, et al. Among authors: sanchez m. Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):741-52. doi: 10.1016/j.addr.2010.01.001. Epub 2010 Jan 25. Adv Drug Deliv Rev. 2010. PMID: 20102730 Review.

10

The importance of understanding what is platelet-rich growth factor (PRGF) and what is not.

Anitua E, Sánchez M, Orive G. Anitua E, et al. Among authors: sanchez m. J Shoulder Elbow Surg. 2011 Jan;20(1):e23-4; author reply e24. doi: 10.1016/j.jse.2010.07.005. Epub 2010 Nov 3. J Shoulder Elbow Surg. 2011. PMID: 21050777 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,877 results

Search Page

Filters